Ginkgo Bioworks
May 16, 2019
Ginkgo to buy mining platform; Vertex, Kymera collaborate; ArcherDX nets $60M; Bayer to invest $150M
Ginkgo announces to buy Warp Drive Bio’s genome mining platform Ginkgo Bioworks has announced to acquire the genome mining platform from Warp Drive Bio, a subsidiary of REVOLUTION Medicines. The acquisition will give Gingko access to Warp Drive Bio's genome mining team, technology, and database. This coll...
Read More...
-Agonist.png "Toll-like Receptors Agonist")
